SpecialtiesQuestion

How do you weigh the decision to extend dual antiplatelet therapy following coronary stenting in an older adult patient in their 80s beyond one year?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

What is your clinical approach to deprescribing vs continuing low-dose aspirin used for primary prevention in older adults who are already taking this medication?

Has the FRAIL-AF trial, which found that switching frail older patients with atrial fibrillation from warfarin to a DOAC was associated with more bleeding rather than less, changed how you approach this transition in your most frail patients successfully treated with warfarin?

How do you discuss the benefits and potential risks of anticoagulation for a strong indication (e.g., atrial fibrillation with high CHA2DS2-Vasc score) with older adult patients with frequent falls?

How do you approach the management of older adult patients with coronary artery disease on aspirin who have developed intermittent diverticular bleeds?

In older adult patients in whom the decision has been made to deprescribe oral anticoagulant therapy (e.g., in a patient with stable atrial fibrillation who has significant bleeding complications), how do you approach cessation of the anticoagulant?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.